# CND Life Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cnd-life-sciences

- Industry: Healthcare
- Headquarters: Scottsdale, US
- Website: www.cndlifesciences.com
- Total disclosed funding: $22M
- Latest round: Series A (May 20, 2025)
- Investors on record: 14

## About

Founded in 2017 by Christopher Gibbons, Roy Freeman, and Todd Dylan Levine, and based in Arizona, US, CND Life Sciences, Inc., formerly known as Cutaneous NeuroDiagnostics, LLC, operates a laboratory that produces alternative aid for neurodegenerative diseases and other conditions. In August 2026, CND Life Sciences, Inc. raised an undisclosed amount of growth capital funding led by VILAS Ventures. The firm’s primary offering is the Syn-One Test®, which detects, visualizes and quantifies misfolded phosphorylated alpha-synuclein in skin nerve fibers. The test aids in diagnosing synucleinopathies, including Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The test involves analyzing skin biopsies for accurate and minimally invasive diagnosis. CND Life Sciences also engages in research collaborations to diagnostic capabilities and explore biomarkers for neurodegenerative diseases. The company will use the August 2026 funding to expand its neurology testing platform, support product development, grow commercial activities, and build biomarker-based diagnostic capabilities.

## Funding rounds

- Series A, May 20, 2025, $14M — S-Curve Partners
- Series A, May 6, 2025, $5.1M — Gold Bench Capital, LabCorp Ventures, Bluestone Venture Partners, MBX Capital, Tanis Venture Management, Top Corner Capital, Triana, Cambrian Capital Partners, HonorHealth, VILAS Ventures, Lupo Labs
- Series A, Feb 28, 2025, $3.5M — Cambrian Capital, Gold Bench Capital, LabCorp Ventures, Bluestone Venture Partners, MBX Capital, Tanis Venture Management, Top Corner Capital, TRIANA Biomedicines, Inc., HonorHealth, VILAS Ventures, Lupo Labs

## Investors

- Cambrian Capital — Series A
- Gold Bench Capital — Series A
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series A
- Bluestone Venture Partners (https://capitalatlas.ai/funds/bluestone-venture-partners) — Series A
- MBX Capital (https://capitalatlas.ai/funds/mbx-capital) — Series A
- Tanis Venture Management (https://capitalatlas.ai/funds/tanis-venture-management) — Series A
- Top Corner Capital (https://capitalatlas.ai/funds/top-corner-capital) — Series A
- TRIANA Biomedicines, Inc. — Series A
- HonorHealth — Series A
- VILAS Ventures — Series A
- Lupo Labs — Series A
- Triana — Series A
- Cambrian Capital Partners — Series A
- S-Curve Partners (https://capitalatlas.ai/funds/s-curve-partners) — Series A